Canada’s cardiac system is designed to respond to specific moments, such as a symptom, an appointment, or a diagnosis. However, heart disease develops over months and years, often before a patient feels unwell. This mismatch has significant consequences, as heart disease remains the second-leading cause of death and a leading cause of hospitalization in Canada.
Despite the importance of prevention, Canada’s response to heart disease is still largely reactive, focusing on treatment after symptoms appear. To effectively prevent heart disease, the country needs infrastructure that enables clinicians to detect meaningful changes earlier, rather than just treating the disease once it’s obvious.
Current Limitations of Cardiac Care
Much of cardiac care relies on snapshots, such as blood-pressure readings, ECGs, or imaging studies, taken at a single point in time. While these tools are essential, they can only provide a glimpse of a patient’s cardiac performance at a particular moment, rather than showing how it changes over time.
Canada needs a new layer of care that provides portable, repeatable, and clinician-reviewed measurements to establish a baseline and track changes over time. This is particularly important for clearly defined groups where the clinical question is not just “What is happening?” but also “What is changing?”
The Need for Longitudinal Cardiac Care
A recent survey found that 17% of people in Canada lack a regular family doctor, nurse practitioner, or primary care setting. Even among those connected to primary care, only 37% of people seeking an urgent appointment obtained one the same or next day, while just 28% were satisfied with how the system was working.
This highlights the need for a prevention model that does not rely solely on repeated access to clinics, specialists, and hospital-based tests.
One example of such technology is Recordis, a portable, non-invasive, and clinical-grade platform developed by LLA Technologies. It captures standardized mechanical cardiac information for review by qualified professionals, providing a longitudinal cardiac intelligence layer between episodic clinical encounters.
Global Challenges and Opportunities
The challenge of managing chronic diseases like heart disease is not unique to Canada. Every country facing aging populations and uneven access is trying to manage conditions that evolve continuously through systems designed around isolated encounters.
However, innovation can help address this challenge. Canadian innovators are developing technologies that can move care closer to patients, create more consistent information between appointments, and help health systems use scarce specialist resources more deliberately.
To evaluate and adopt these innovations, provinces, health authorities, and research institutions should work together to create structured pilots for longitudinal cardiac technologies. These pilots should measure reliability, usability, equity, privacy, interoperability, and whether the information changes care.
Ultimately, Canada does not need to choose between trusted tests and new technologies. By doing so, Canada can improve its cardiac care system and reduce the burden of heart disease on its population.
